Aegerion Pharma Files for IPO

Aegerion Pharmaceuticals Inc., a Bridgewater, N.J.-based drug company being incubated by life sciences advisory Scheer & Co., has filed to raise $86.25 million via an IPO. It plans to trade on the Nasdaq under ticker symbol AEGR, with Lehman Brothers serving as lead underwriter. The company raised around $22.5 million in Series A funding in 2005 from firms like Alta Partners, Advent International, Index Ventures, MVM Life Science Partners and Scheer & Co.